Webinar
Deep Tech Fund Launch
Join Alumni Ventures Managing Partner Matt Caspari for an introduction to the Deep Tech Fund, a unique investment opportunity focused on cutting-edge innovations shaping the future.
In this session, Matt will outline the fund’s thesis, sourcing strategy, and how the team identifies transformative technologies across sectors like quantum computing, space, advanced materials, and AI infrastructure. He’ll also share insights into emerging deep tech trends, early portfolio activity, and how Alumni Ventures evaluates startups operating on the frontiers of science and engineering.
Whether you’re a seasoned investor or just curious about deep tech, this webinar will provide clarity on how to access and navigate this exciting segment of venture capital. Attendees will have the chance to ask questions and learn how to get involved. Reserve your spot today for an exclusive look into one of the most dynamic areas of innovation investing.
Why Attend?
- HomeLearn how the Deep Tech Fund targets breakthrough innovations with long-term impact
- HomeUnderstand Alumni Ventures’ approach to sourcing and evaluating frontier technologies
- HomeGain early exposure to emerging startups at the intersection of science and commercialization
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Managing Partner, Deep Tech Fund
Matt Caspari is a Managing Partner at Alumni Ventures, where he leads the Deep Tech, Georgetown (Potomac Ventures) and UC Berkeley (Strawberry Creek Ventures) funds. He invests in mission-driven founders developing groundbreaking technologies. His investments encompass a diverse range of sectors, including AI, agriculture, aviation, battery technology, cybersecurity, direct air capture of CO2, energy generation, longevity, and robotics. Prior to Alumni Ventures, Matt gained operational experience as a two-time venture-backed founder/CEO and as a leader of the innovation team at Nike. He was the founding CEO of Aurora Biofuels, a deep tech venture that grew to 100+ employees, secured over $100 million in funding and was acquired by Reliance Industries. In earlier roles, Matt served as a strategic management consultant at Cambridge Pharma Consultancy, later acquired by IMS Health, and gained experience on the M&A team at Bloomberg. He holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.